Omar Khan O. Efficacy and safety of CTLA-4, PD-1 and LAG-3 immune checkpoint inhibitors as monotherapy and combination therapy in advanced melanoma: A systematic review and meta-analysis. EXCLI J. [Internet]. 2026 Jan. 30 [cited 2026 Jun. 6];25:310-29. Available from: https://www.excli.de/excli/article/view/9096